Connaissances Accueil Santé humaine Connaissances All Avis Exposés Science populaire Entretiens Filtrer Therapeutic areasCOVID-19Santé digestive Apply Accueil Santé humaine Connaissances Test of Safety and immunogenicity of a PHH-1V booster dose after different prime vaccination schemes against COVID-19: Phase III clinical trial final results up to one year Accueil Santé humaine Connaissances Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Accueil Santé humaine Connaissances Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Accueil Santé humaine Connaissances Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Accueil Santé humaine Connaissances Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Accueil Santé humaine Connaissances Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Accueil Santé humaine Connaissances Safety and immunogenicity of PHH-1V as booster vaccination through the Omicron era: results from a phase IIb open-label extension study up to 6 months Accueil Santé humaine Connaissances Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial Accueil Santé humaine Connaissances Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Charger plus
